Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors.

Added 616 days ago (10.09.2020)
Authors: Niu Y, Lin A, Luo P, Zhu W, Wei T, Tang R, Guo L, Zhang J
PubMed id: 32903385
Read article